Erratum to: A Novel "Molecular Tweezer" Inhibitor of α-Synuclein Neurotoxicity In Vitro and In Vivo (Neurotherapeutics, 10.1007/s13311-012-0105-1);A Novel "Molecular Tweezer" Inhibitor of α-Synuclein Neurotoxicity in Vitro and in Vivo

Neurotherapeutics

Volumn 9, Issue 2, 2012, Pages 464-476

  Prabhudesai, Shubhangi ^a   Sinha, Sharmistha ^a   Attar, Aida ^a   Kotagiri, Aswani ^a   Fitzmaurice, Arthur G ^a   Lakshmanan, Ravi ^b   Ivanova, Magdalena I ^a   Loo, Joseph A ^b   Klärner, Frank Gerrit ^d   Schrader, Thomas ^d   Stahl, Mark ^a   Bitan, Gal ^a,b   Bronstein, Jeff M ^a,b,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d UNIVERSITY OF DUISBURG ESSEN   (Germany)

Author keywords

amyloid; neuroprotection; Parkinson's disease; synucleinopathy; zebrafish

Indexed keywords

ALPHA SYNUCLEIN; CLR 01; PROTEIN INHIBITOR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; DRUG PROTEIN BINDING; EMBRYO; IC 50; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; MOLECULAR WEIGHT; NERVE CELL; NEUROTOXICITY; NONHUMAN; OLIGOMERIZATION; PHENOTYPE; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN ASSEMBLY; PROTEIN EXPRESSION; SURVIVAL; ZEBRA FISH;

EID: 84859708060     PISSN: 19337213     EISSN: 18787479     Source Type: Journal    
DOI: 10.1007/s13311-012-0120-2     Document Type: Erratum

References (56)

1. Nussbaum, R. L. and M. H. Polymeropoulos, Genetics of Parkinson's disease. Hum Mol Genet, 1997. 6(10): p. 1687-91.
2. Kruger, R., Kuhn, W, Muller, T, et al., Ala30Pro mutation in the gene encoding α-synuclein in Parkinson's disease. Nat Genet, 1998. 18(2): p. 106-8.
3. Trojanowski, J. Q., Goedert, M., Iwatsubo, T., and Lee, V. M. Fatal attractions: abnormal protein aggregation and neuron death in Parkinson's disease and Lewy body dementia. Cell Death Differ, 1998. 5(10): p. 832-7.
4. Spillantini, M. G., Schmidt, M. L., Lee, V. M., Trojanowski, J. Q., Jakes, R., and Goedert, M. α-synuclein in Lewy bodies. Nature, 1997. 388(6645): p. 839-40.
5. Farrer, M., Kachergus, J., Forno, L., et al., Comparison of kindreds with parkinsonism and α-synuclein genomic multiplications. Ann Neurol, 2004. 55(2): p. 174-9.
6. Betarbet, R., Canet-Aviles, R. M., Sherer, T. B. et al., Intersecting pathways to neurodegeneration in Parkinson's disease: Effects of the pesticide rotenone on DJ-1, α-synuclein, and the ubiquitin-proteasome system. Neurobiol Dis, 2006. 22(2): p. 404-20.
7. Chou, A. P., Maidment, N., Klintenberg, R. et al., Ziram causes dopaminergic cell damage by inhibiting E1 ligase of the proteasome. The Journal of biological chemistry, 2008. 283(50): p. 34696-703.
8. McCormack, A. L. and D. A. Di Monte, Enhanced α-synuclein expression in human neurodegenerative diseases: pathogenetic and therapeutic implications. Current protein & peptide science, 2009. 10(5): p. 476-82.
9. Fokkens, M., T. Schrader, and F. G. Klärner, A molecular tweezer for lysine and arginine. Journal of the American Chemical Society, 2005. 127(41): p. 14415-14421.
10. Sinha, S., Lopes, D.H., Du, Z. et al., Lysine-specific molecular tweezers are broadspectrum inhibitors of assembly and toxicity of amyloid proteins. Journal of the American Chemical Society, 2011. 133(42): p. 16958-69.
11. LeVine, H., 3rd, Quantification of β-sheet amyloid fibril structures with thioflavin T. Methods in Enzymology, 1999. 309: p. 274-84.
12. Rahimi, F., P. Maiti, and G. Bitan, Photo-induced cross-linking of unmodified proteins (PICUP) applied to amyloidogenic peptides. Journal of visualized experiments: J Vis Exp. 2009 (23): http://www. jove. com/index/details. stp?id=1071.
13. Wang, X.-F., Li, S., Chou, A. P. and Bronstein, J. M. Inhibitory effects of pesticides on proteasome activity: Implication in Parkinson's disease. Neurobiology of Disease, 2006. 23(1): p. 198-205.
14. Fradinger, E. A., Monien, B. H., Urbanc, B. et al., C-terminal peptides coassemble into Aβ42 oligomers and protect neurons against Aβ42-induced neurotoxicity. Proceedings of the National Academy of Sciences of the United States of America, 2008. 105(37): p. 14175-80.
15. Westerfield, M., The Zebrafish Book: A Guide for the Laboratory Use of Zebrafish (Danio rerio). 4th Edition 2000, Eugene: University of Oregon Press.
16. Szymczak, A. L., Workman, C. J., Wang, Y., et al., Correction of multi-gene deficiency in vivo using a single 'self-cleaving' 2A peptide-based retroviral vector. Nat Biotechnol, 2004. 22(5): p. 589-94.
17. Thermes, V., Grabher, C., Ristoratore, F., et al., I-SceI meganuclease mediates highly efficient transgenesis in fish. Mech Dev, 2002. 118(1-2): p. 91-8.
18. Bence, N. F., R. M. Sampat, and R. R. Kopito, Impairment of the ubiquitin-proteasome system by protein aggregation. Science, 2001. 292(5521): p. 1552-5.
19. Bronstein, J., Wasterlain, C. G., Lasher, R., and Farber, D. B. Dark-induced changes in activity and compartmentalization of retinal calmodulin kinase in the rat. Brain Res, 1989. 495(1): p. 83-8.
20. McCurley, A. T. and G. V. Callard, Characterization of housekeeping genes in zebrafish: male-female differences and effects of tissue type, developmental stage and chemical treatment. BMC molecular biology, 2008. 9: p. 102.
21. Bitan, G., Fradinger, E. A., Spring, S. M., and Teplow, D. B. Neurotoxic protein oligomers--what you see is not always what you get. Amyloid: the international journal of experimental and clinical investigation: the official journal of the International Society of Amyloidosis, 2005. 12(2): p. 88-95.
22. Desplats, P., Lee, H. J., Bae, E. J., et al., Inclusion formation and neuronal cell death through neuron-to-neuron transmission of α-synuclein. Proceedings of the National Academy of Sciences USA, 2009. 106(31): p. 13010-5.
23. Luk, K. C., Song, C., O'Brien, P., et al., Exogenous α-synuclein fibrils seed the formation of Lewy body-like intracellular inclusions in cultured cells. Proceedings of the National Academy of Sciences USA, 2009. 106(47): p. 20051-6.
24. Danzer, K. M., Krebs, S. K., Wolff, M., Birk, G., and Hengerer, B. Seeding induced by α-synuclein oligomers provides evidence for spreading of α-synuclein pathology. Journal of Neurochemistry, 2009. 111(1): p. 192-203.
25. Rink, E. and M. F. Wullimann, The teleostean (zebrafish) dopaminergic system ascending to the subpallium (striatum) is located in the basal diencephalon (posterior tuberculum). Brain Res, 2001. 889(1-2): p. 316-30.
26. Rodriguez-Mari, A., Canestro, C., Bremiller, R. A. et al., Sex reversal in zebrafish fancl mutants is caused by Tp53-mediated germ cell apoptosis. PLoS Genetics, 2010. 6(7): p. e1001034.
27. Snyder, H., Aggregated and Monomeric α -Synuclein Bind to the S6' Proteasomal Protein and Inhibit Proteasomal Function. Journal of Biological Chemistry, 2003. 278(14): p. 11753-11759.
28. Madine, J., A. J. Doig, and D. A. Middleton, Design of an N-methylated peptide inhibitor of α-synuclein aggregation guided by solid-state NMR. Journal of the American Chemical Society, 2008. 130(25): p. 7873-81.
29. Li, J., Zhu, M., Manning-Bog, A. B., Di Monte, D. A. and Fink, A. L. Dopamine and L-dopa disaggregate amyloid fibrils: implications for Parkinson's and Alzheimer's disease. The FASEB journal: official publication of the Federation of American Societies for Experimental Biology, 2004. 18(9): p. 962-4.
30. Li, J., Zhu, M., Rajamani, S., Uversky, V. N. and Fink, A. L Rifampicin inhibits α-synuclein fibrillation and disaggregates fibrils. Chemistry & biology, 2004. 11(11): p. 1513-21.
31. Pandey, N., Strider, J., Nolan, W. C., Yan, S. X., and Galvin, J. E. Curcumin inhibits aggregation of α-synuclein. Acta Neuropathologica, 2008. 115(4): p. 479-89.
32. Masuda, M., Suzuki, N., Taniguchi, S., et al., Small molecule inhibitors of α-synuclein filament assembly. Biochemistry, 2006. 45(19): p. 6085-94.
33. Masuda, M., Hasegawa, M., Nonaka, T. et al., Inhibition of α-synuclein fibril assembly by small molecules: analysis using epitope-specific antibodies. FEBS Letters, 2009. 583(4): p. 787-91.
34. Rao, J. N., V. Dua, and T. S. Ulmer, Characterization of α-synuclein interactions with selected aggregation-inhibiting small molecules. Biochemistry, 2008. 47(16): p. 4651-6.
35. Amer, D. A., G. B. Irvine, and O. M. El-Agnaf, Inhibitors of α-synuclein oligomerization and toxicity: a future therapeutic strategy for Parkinson's disease and related disorders. Experimental brain research. Experimentelle Hirnforschung. Experimentation cerebrale, 2006. 173(2): p. 223-33.
36. Ehrnhoefer, D. E., Bieschke, J., Boeddrich, A. et al., EGCG redirects amyloidogenic polypeptides into unstructured, off-pathway oligomers. Nature structural & molecular biology, 2008. 15(6): p. 558-66.
37. Rishton, G. M., Aggregator compounds confound amyloid fibrillization assay. Nature Chemical Biology, 2008. 4(3): p. 159-60.
38. Feng, B. Y., Toyama, B. H., Wille, H. et al., Small-molecule aggregates inhibit amyloid polymerization. Nature Chemical Biology, 2008. 4(3): p. 197-9.
39. Sulzer, D., Clues to how α-synuclein damages neurons in Parkinson's disease. Movement disorders: official journal of the Movement Disorder Society, 2010. 25 Suppl 1: p. S27-31.
40. Karpinar, D. P., Balija, M. B., Kugler, S. et al., Pre-fibrillar α-synuclein variants with impaired β-structure increase neurotoxicity in Parkinson's disease models. The EMBO journal, 2009. 28(20): p. 3256-68.
41. Uversky, V. N., α-synuclein misfolding and neurodegenerative diseases. Current protein & peptide science, 2008. 9(5): p. 507-40.
42. Emmanouilidou, E., L. Stefanis, and K. Vekrellis, Cell-produced α-synuclein oligomers are targeted to, and impair, the 26S proteasome. Neurobiology of Aging, 2010. 31(6): p. 953-968.
43. Zhang, N. Y., Z. Tang, and C. W. Liu, α-Synuclein protofibrils inhibit 26 S proteasome-mediated protein degradation: understanding the cytotoxicity of protein protofibrils in neurodegenerative disease pathogenesis. The Journal of biological chemistry, 2008. 283(29): p. 20288-98.
44. Tseng, B. P., Green, K. N., Chan, J. L., Blurton-Jones, M., and LaFerla, F. M. Aβ inhibits the proteasome and enhances amyloid and tau accumulation. Neurobiology of Aging, 2008. 29(11): p. 1607-18.
45. Casas, S., Gomis, R., Gribble, F. M., Altirriba, J., Knuutila, S., and Novials, A. Impairment of the ubiquitin-proteasome pathway is a downstream endoplasmic reticulum stress response induced by extracellular human islet amyloid polypeptide and contributes to pancreatic β-cell apoptosis. Diabetes, 2007. 56(9): p. 2284-94.
46. Costes, S., Huang, C. J., Gurlo, T. et al., β-cell dysfunctional ERAD/ubiquitin/proteasome system in type 2 diabetes mediated by islet amyloid polypeptide-induced UCH-L1 deficiency. Diabetes, 2011. 60(1): p. 227-38.
47. Ortega, Z., Diaz-Hernandez, M., Maynard, C. J., Hernandez, F., Dantuma, N. P., and Lucas, J. J. Acute polyglutamine expression in inducible mouse model unravels ubiquitin/proteasome system impairment and permanent recovery attributable to aggregate formation. The Journal of neuroscience: the official journal of the Society for Neuroscience, 2010. 30(10): p. 3675-88.
48. McNaught, K. S. and P. Jenner, Proteasomal function is impaired in substantia nigra in Parkinson's disease. Neurosci Lett, 2001. 297(3): p. 191-4.
49. McNaught, K. S., Olanow, C. W., Halliwell, B., Isacson, O., and Jenner, P. Failure of the ubiquitin-proteasome system in Parkinson's disease. Nat Rev Neurosci, 2001. 2(8): p. 589-94.
50. Bove, J., Zhou, C., Jackson-Lewis, V., et al., Proteasome inhibition and Parkinson's disease modeling. Annals of Neurology, 2006. 60(2): p. 260-4.
51. Kordower, J. H., Kanaan, N. M., Chu, Y., Suresh Babu, R., and Stansell, J., Failure of proteasome inhibitor administration to provide a model of Parkinson's disease in rats and monkeys. Annals of Neurology, 2006. 60(2): p. 264-8.
52. Manning-Bog, A. B., Reaney, S. H., Chou, V. P. et al., Lack of nigrostriatal pathology in a rat model of proteasome inhibition. Annals of Neurology, 2006. 60(2): p. 256-60.
53. McNaught, K. S. and C. W. Olanow, Proteasome inhibitor-induced model of Parkinson's disease. Annals of Neurology, 2006. 60(2): p. 243-7.
54. Schapira, A. H., Cleeter, M. W., Muddle, J. R., Workman, J. M., Cooper, J. M., and King, R. H. Proteasomal inhibition causes loss of nigral tyrosine hydroxylase neurons. Annals of Neurology, 2006. 60(2): p. 253-5.
55. Zeng, B. Y., Bukhatwa, S., Hikima, A., Rose, S., and Jenner, P. Reproducible nigral cell loss after systemic proteasomal inhibitor administration to rats. Annals of Neurology, 2006. 60(2): p. 248-52.
56. Martinez-Vicente, M., Talloczy, Z., Kaushik, S., et al., Dopamine-modified α-synuclein blocks chaperone-mediated autophagy. Journal of Clinical Investigation, 2008. 118(2): p. 777-788.